DexCom Inc (DXCM) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.
Over the past 4 years, DexCom Inc has achieved a revenue compound annual growth rate (CAGR) of 20.3%, while earnings have grown at 1.2% CAGR.
Historical revenue and profitability trends for DexCom Inc
The chart above illustrates DexCom Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of DexCom Inc's business.
How efficiently DexCom Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue DexCom Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project DexCom Inc to continue growing earnings in the coming year. The consensus analyst rating is 4.5385 based on 26 analysts.
Based on our comprehensive analysis, DexCom Inc (DXCM) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of DexCom Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how DexCom Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: DXCM Valuation, DXCM Dividend, DXCM Financial Health
Compare: DXCM vs AAPL, DXCM vs MSFT, DXCM vs GOOGL